Author

J. M. Dixon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

A. H. Sims· 2 shared A. K. Turnbull· 2 shared A. Fernando· 1 shared A. Li· 1 shared C. Oxvig· 1 shared C. Selli· 1 shared D. A. Pearce· 1 shared H. Zhao· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. H. Sims

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of stromal genes differentially expressed in lobular breast cancer highlights role for pregnancy-associated-plasma protein-A

L. Gomez-Cuadrado, H. Zhao, M. Souleimanova, P. R. Noer, A. K. Turnbull, C. Oxvig, N. Bertos, J. M. Dixon, M. Park, A. H. Sims, V. G. Brunton

The paper identifies stromal genes differentially expressed in lobular breast cancer, highlighting pregnancy-associated-plasma protein-A (PAPPA) as a potential prognostic marker.

bioRxiv · Apr 24, 2020 · PreprintCancer Biology

Molecular changes during extended neoadjuvant letrozole treatment of breast cancer: distinguishing acquired resistance from dormant tumours

C. Selli, A. K. Turnbull, D. A. Pearce, A. Li, A. Fernando, J. Wills, L. Renshaw, J. S. Thomas, J. M. Dixon, A. H. Sims

This study compares molecular changes in dormant and acquired resistant breast cancer tumors during extended letrozole treatment, finding distinct epigenetic alterations in resistant tumors.

bioRxiv · Sep 25, 2018Cancer Biology